Glaxo’s Shingles Vaccine Helps Boost Earnings Over Estimates

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc’s shingles vaccine helped counter new competition for its aging asthma treatment as the U.K. drugmaker posted first-quarter earnings that beat analysts’ estimates.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.